Improving Antibody‐Tubulysin Conjugates through Linker Chemistry and Site‐Specific Conjugation

Tubulysins have emerged in recent years as a compelling drug class for delivery to tumor cells via antibodies. The ability of this drug class to exert bystander activity while retaining potency against multidrug‐resistant cell lines differentiates them from other microtubule‐disrupting agents. Tubul...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Joseph Z., Pires, Thomas A., Mitchell, Jamie A., Cochran, Julia H., Emmerton, Kim K., Zaval, Margo, Stone, Ivan J., Anderson, Martha E., Jin, Steven, Waight, Andrew B., Lyon, Robert P., Senter, Peter D., Jeffrey, Scott C., Burke, Patrick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048973/
https://www.ncbi.nlm.nih.gov/pubmed/33369163
http://dx.doi.org/10.1002/cmdc.202000889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048973/
https://www.ncbi.nlm.nih.gov/pubmed/33369163
http://dx.doi.org/10.1002/cmdc.202000889

Ejemplares similares